Product NDC: | 0068-0509 |
Proprietary Name: | Rifamate |
Non Proprietary Name: | rifampin and isoniazid |
Active Ingredient(s): | 150; 300 mg/1; mg/1 & nbsp; rifampin and isoniazid |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0068-0509 |
Labeler Name: | sanofi-aventis U.S. LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA061884 |
Marketing Category: | ANDA |
Start Marketing Date: | 19750711 |
Package NDC: | 0068-0509-60 |
Package Description: | 60 CAPSULE in 1 BOTTLE (0068-0509-60) |
NDC Code | 0068-0509-60 |
Proprietary Name | Rifamate |
Package Description | 60 CAPSULE in 1 BOTTLE (0068-0509-60) |
Product NDC | 0068-0509 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | rifampin and isoniazid |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 19750711 |
Marketing Category Name | ANDA |
Labeler Name | sanofi-aventis U.S. LLC |
Substance Name | ISONIAZID; RIFAMPIN |
Strength Number | 150; 300 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Rifamycin Antibacterial [EPC],Rifamycins [Chemical/Ingredient],Antimycobacterial [EPC] |